The Experimental Cancer Treatment Unit (ECRU) was set up with the purpose of academically enhancing support for early phase clinical trials. Its focus is on providing a single point of engagement for the conduct of Phase 0/1/2 trials. The unit is part of the Department of Medical Oncology and was initiated in 2009. The core team collaborates closely with other clinicians and scientists committed to preclinical and clinical development of new anticancer drugs. Our core interests covers all solid tumours and lymphomas.
At ECRU, we coordinate the aspects of modern drug development from target discovery and validation, xenograft drug screening, clinical pharmacology and biomarker correlative clinical trials. This includes the ability to do sequential tumor biopsies for biomarker development in certain trials.
Mission of ECRU:
Copyright © 2015 National Cancer Centre of Singapore Pte Ltd. All Rights Reserved.
Want to live happier and healthier?
Sign up for our newsletter for practical health tips.
Thanks for subscribing!
You're almost done. Check your email and click the link to confirm your subscription.